Holen Sie sich die Stockscreener-App
17.18
0.62%
0.15
Finanzdaten der Moonlake Immunotherapeutics-Aktie (MLTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
8.70%
65.22
|
71.43 | 60.70 | 47.48 | 49.58 |
| Operating Income/Loss |
8.70%
-65.22
|
-71.43 | -60.70 | -47.48 | -49.58 |
| Income/Loss From Continuing Operations Before Tax |
11.06%
-62.77
|
-70.58 | -56.05 | -40.56 | -46.35 |
| Income Tax Expense/Benefit |
115.65%
0.248
|
0.115 | 0.095 | 0.153 | 0.0411 |
| Income/Loss From Continuing Operations After Tax |
10.86%
-63.02
|
-70.69 | -56.05 | -40.56 | -46.40 |
|
Net Income/Loss
|
10.86%
-63.02
|
-70.69 | -56.05 | -40.56 | -46.40 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
38.76%
-0.591
|
-0.965 | -0.831 | -0.615 | -0.7912 |
| Basic Average Shares |
98.16%
1.1679
|
63.37 | 63.28 | 63.23 | 0.067 |
| Diluted Average Shares |
98.16%
1.1679
|
63.37 | 63.28 | 63.23 | 0.067 |
| Basic Earnings Per Share |
16.36%
-0.92
|
-1.10 | -0.87 | -0.63 | -0.72 |
| Diluted Earnings Per Share |
16.36%
-0.92
|
-1.10 | -0.87 | -0.63 | -0.72 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):